Dermatologic investigation of betamethasone 17,21-dipropionate ointment with chinoform.
In an open investigation on 50 patients with various dermatological lesions 17 (81%) out of 21 psoriatics and 28 out of 29 other patients inproved considerably or were clinically cured after three weeks' treatment with an ointment containing 0-05% betamethasone dipropionate and 3-0% chinoform. Among the patients chosen for the study 34 had previously tried topical corticosteroids without success. Of these 31 improved markedly during the steroid trial.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007464:Clioquinol / Q000008:administration & dosage* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy
D004338:Drug Combinations; D009824:Ointments; D007464:Clioquinol; D001623:Betamethasone